CRT is overexpressed in invasive breast cancer tissues relative to normal tissues, suggesting that it is involved in this cancer phenotype through dysregulation of the p53 and mitogen-activated protein kinase signaling pathways [89]. This evidence concerns the gene CALR and breast cancer.